Assessment of the Accuracy of PET/MR in Detection and Monitoring Response of Bone Metastases

Tel Aviv Sourasky Medical Center

Status: Unknown

Conditions: Bone Metastases

Treatments: Diagnostic Test: PET/MR

Study type: Interventional

Funder types: Other

Identifiers

NCT04159376

TASMC-19-ES-0574-CTIL

Details and patient eligibility

About

The great promise of PET/MR for assessment of skeletal metastatic involvement is derived from the extensive experience with stand- alone MR, but initial data on the use of PET/MR for assessment of bone pathology indicate that PET/MR introduces unique issues that should be addressed when determining its role in this clinical scenario.

In this study cohort includes 150 patients 18 years or older, having metastatic skeletal involvement on baseline PET/CT prior to treatment. Baseline studies and follow up studies of the patients referred post treatment, will be reviewed.

The main goal of the study is to asses the accuracy of PET/MR in detection and monitoring response of bone metastases.

Enrollment: 150 estimated patients

Sex: All

Ages: 18 to 120 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

150 patients having metastatic skeletal involvement on baseline PET/CT prior to treatment

Exclusion criteria

1. Age <18.
2. Pregnant or breast feeding patients.

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

150 participants in 1 patient group

Bone Metastases Patients

Experimental group

Treatment:

Diagnostic Test: PET/MR